Form 144: Proposed sale of 50,000 RSUs

Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to a proposed sale of 50,000 Restricted Stock Units of common stock, dated 05/21/2025.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to a proposed sale of 50,000 Restricted Stock Units of common stock, dated 05/21/2025. The filing also lists recent 10b5-1 sales by Gabriel Mecklenburg: examples include 06/01/2026 (83,334 shares for $5,018,130.15) and 06/05/2026 (50,000 shares for $3,276,840.00).

Insights

Securities Counsel

Form 144 records a proposed broker-facilitated resale and shows recent Rule 10b5-1 transactions.

The filing lists a proposed sale of 50,000 Restricted Stock Units dated 05/21/2025, submitted via Morgan Stanley Smith Barney LLC. It also itemizes completed 10b5-1 sales by Gabriel Mecklenburg on specific dates with gross proceeds.

Regulatory context: Form 144 is a notice of intent to sell restricted/controlled securities under Rule 144; the presence of 10b5-1 entries indicates some sales were executed under prearranged plans. Cash-flow treatment and ultimate purchaser details are not provided in the excerpt.

Key Figures

Proposed sale: 50,000 shares 10b5-1 sale: 83,334 shares 10b5-1 sale: 50,000 shares +2 more

5 metrics

Proposed sale 50,000 shares Restricted Stock Units dated <date>05/21/2025</date>

10b5-1 sale 83,334 shares <date>06/01/2026</date> sale for <money>$5,018,130.15</money>

10b5-1 sale 50,000 shares <date>06/05/2026</date> sale for <money>$3,276,840.00</money>

10b5-1 sale 83,333 shares <date>05/26/2026</date> sale for <money>$4,482,883.73</money>

10b5-1 sale 33,333 shares <date>04/21/2026</date> sale for <money>$1,501,528.32</money>

Key Terms

Restricted Stock Units, 10b5-1, Form 144

3 terms

Restricted Stock Units financial

"Securities To Be Sold: Restricted Stock Units dated 05/21/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for GABRIEL MECKLENBURG listed with dates and amounts"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information and Securities To Be Sold sections reference Form 144 notice"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Morgan Stanley Smith Barney LLC's Form 144 filing for HNGE show?

It shows a proposed sale of 50,000 Restricted Stock Units dated 05/21/2025. The filing lists the broker as Morgan Stanley Smith Barney LLC and includes recent 10b5-1 sale entries by Gabriel Mecklenburg.

Which recent 10b5-1 sales for HNGE are listed in the excerpt?

Examples include 06/01/2026 sale of 83,334 shares for $5,018,130.15 and 06/05/2026 sale of 50,000 shares for $3,276,840.00. Several other dated sales appear in the table.

Does the Form 144 excerpt state who will receive the proceeds from the sale?

The excerpt does not specify proceeds recipients. It lists gross proceeds for specific 10b5-1 sales but does not state whether proceeds go to the issuer or selling holder in the proposed sale notice.

What does the presence of 10b5-1 entries indicate for HNGE insider activity?

The entries show that some sales were executed under 10b5-1 plans on specific dates, such as 05/26/2026 and 04/21/2026. The filing lists quantities and gross proceeds for each recorded sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:51 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002062781
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HINGE HEALTH, INC.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	GABRIEL MECKLENBURG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Exec. Chairman & Co-Founder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4150000.00	54655926	07/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock Units	Issuer			50000	05/21/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	06/05/2026	50000	3276840.00
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	06/01/2026	83334	5018130.15
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	05/26/2026	83333	4482883.73
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	05/06/2026	50000	2750435.00
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	04/21/2026	33333	1501528.32

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gabriel Mecklenburg
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)